Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Ryan

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of the American College of Cardiology|June 27, 2015
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next LevelAna Barac, Gillian Murtagh, Joseph R Carver, et al.
Blood|January 15, 2020
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumabSonata Jodele, Christopher E Dandoy, Adam Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2018
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and PreventionSaro H Armenian, Gregory T Armstrong, Gregory Aune, et al.
Journal of the American College of Cardiology|December 21, 2019
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council PerspectivesSarju Ganatra, Joseph R Carver, Salim S Hayek, et al.
Pediatric Blood & Cancer|March 27, 2026
CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved DoseJonathan D Bender, Lauren Pommert, Lori R Backus, et al.
Cardio-Oncology (London, England)|March 11, 2020
The landscape of cardiovascular care in pediatric cancer patients and survivors: a survey by the ACC Pediatric Cardio-Oncology Work GroupThomas D Ryan, William L Border, Carissa Baker-Smith, et al.
Pediatric Blood & Cancer|March 9, 2017
Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipientsChristopher E Dandoy, Sonata Jodele, Zachary Paff, et al.
JACC. Heart Failure|November 9, 2024
The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic CardiomyopathyMonica Ahluwalia, Jiankang Liu, Iacopo Olivotto, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
Circulation|May 25, 2023
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe RegistrySarah Abou Alaiwi, Thomas M Roston, Peter Marstrand, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of the American College of Cardiology|June 27, 2015
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next LevelAna Barac, Gillian Murtagh, Joseph R Carver, et al.
Blood|January 15, 2020
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumabSonata Jodele, Christopher E Dandoy, Adam Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2018
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and PreventionSaro H Armenian, Gregory T Armstrong, Gregory Aune, et al.
Journal of the American College of Cardiology|December 21, 2019
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council PerspectivesSarju Ganatra, Joseph R Carver, Salim S Hayek, et al.
Pediatric Blood & Cancer|March 27, 2026
CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved DoseJonathan D Bender, Lauren Pommert, Lori R Backus, et al.
Cardio-Oncology (London, England)|March 11, 2020
The landscape of cardiovascular care in pediatric cancer patients and survivors: a survey by the ACC Pediatric Cardio-Oncology Work GroupThomas D Ryan, William L Border, Carissa Baker-Smith, et al.
Pediatric Blood & Cancer|March 9, 2017
Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipientsChristopher E Dandoy, Sonata Jodele, Zachary Paff, et al.
JACC. Heart Failure|November 9, 2024
The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic CardiomyopathyMonica Ahluwalia, Jiankang Liu, Iacopo Olivotto, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
Circulation|May 25, 2023
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe RegistrySarah Abou Alaiwi, Thomas M Roston, Peter Marstrand, et al.
Pageof 10